Delivery Order SPE2DB22D2214-SPE2DB24FS5UE

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ONFI 10 MG TABLET 100S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $3,432.96, is a Firm Fixed Price Delivery Order that runs through June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,777.42 Firm Fixed Price Delivery Order contract is for the supply of 4567361471 - ONFI 10 MG TABLET 100S, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,872.23 firm fixed-price delivery order is for the supply of 4567296220 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,694.52 firm fixed-price delivery order is for the provision of 4567082062 - ONFI 20 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,866.05 award is for the delivery of 4,565,091 units of the pharmaceutical product ONFI 10 MG TABLET 100S. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4567571551 ! ONFI 10 MG TABLET 100S. The contract has a firm fixed price of $3,020.68 and a completion date of March 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567394741 ONFI 10 MG TABLET 100S, with a ceiling value of $2,008.80 and a completion date of February 27, 2025. The contract is a Firm Fixed Price (FFP) instrument, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,384.19 Firm Fixed Price Delivery Order is for the supply of 4566436494 ! ONFI 10 MG TABLET 100S, with a completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,246.00 Firm Fixed Price delivery order is for the supply of 4,566,208,979 units of ONFI 10 MG TABLET, with an ultimate completion date of October 28, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order under contract SPE2DX15D3008 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,158.72 firm-fixed-price order is for the supply of 4,564,286,755 ONFI 10 MG tablets in 100-count bottles. Amerisourcebergen has a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 to provide a wide range of pharmaceutical products and medical...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5UE
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corporation's Corporate Office division is for the delivery of 4565130589 ONFI 20 MG TABLET 100S to the Defense Logistics Agency (DLA). The fixed-price delivery order contract, valued at $11,011.62, has a completion date of July 15, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to the Department of Defense worldwide. This contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 10/11/24, 9:33 AM